The Latest Breaking News from Arbutus Biopharma

Arbutus Biopharma: Q1 Earnings Insights

  Arbutus Biopharma (NASDAQ:ABUS) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Benzinga · May 5, 2022

Arbutus Biopharma Earnings Conference Call Is Coming Up, Here's What You Need To Know

  Arbutus Biopharma (NASDAQ:ABUS) will host a conference call at 08:45 AM ET on May 5, 2022, to discuss Q1 2022 earnings results.

Benzinga · Apr 28, 2022

Arbutus Biopharma Earnings Perspective: Return On Capital Employed

Benzinga Pro data, Arbutus Biopharma (NASDAQ:ABUS) reported Q4 sales of $3.21 million. Earnings fell to a loss of $21.32 million, resulting in a 11.29% decrease from last quarter.

Benzinga · Mar 9, 2022